Literature DB >> 4113680

Long-incubation (virus B, HAA-associated) hepatitis.

S Sherlock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4113680      PMCID： PMC1412155          DOI： 10.1136/gut.13.4.297

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  50 in total

1.  Additional specificities of Australia antigen and the possible identification of hepatitis carriers.

Authors:  C Levene; B S Blumberg
Journal:  Nature       Date:  1969-01-11       Impact factor: 49.962

2.  The use of gamma-globulin in the prophylaxis of transfusion hepatitis.

Authors:  W Creutzfeldt; H J Severidt; H Brachmann; G Schmidt; U Tschaepe
Journal:  Ger Med Mon       Date:  1967-03

3.  A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis.

Authors:  B S Blumberg; B J Gerstley; D A Hungerford; W T London; A I Sutnick
Journal:  Ann Intern Med       Date:  1967-05       Impact factor: 25.391

4.  A classification of chronic hepatitis.

Authors:  J De Groote; V J Desmet; P Gedigk; G Korb; H Popper; H Poulsen; P J Scheuer; M Schmid; H Thaler; E Uehlinger
Journal:  Lancet       Date:  1968-09-14       Impact factor: 79.321

5.  Immunoglobulin for the prevention of infectious hepatitis in persons working overseas.

Authors:  T M Pollock; D Reid
Journal:  Lancet       Date:  1969-02-08       Impact factor: 79.321

6.  Hepatitis antigen. Correlation with disease and infectivity of blood-donors.

Authors:  D J Gocke; N B Kavey
Journal:  Lancet       Date:  1969-05-31       Impact factor: 79.321

7.  Hepatitis-associated antigen in chronic liver disease.

Authors:  R A Fox; S P Niazi; S Sherlock
Journal:  Lancet       Date:  1969-09-20       Impact factor: 79.321

8.  Relation of Australia-SH antigen to the willowbrook MS-2 strain.

Authors:  J P Giles; R W McCollum; L W Berndtson; S Krugman
Journal:  N Engl J Med       Date:  1969-07-17       Impact factor: 91.245

9.  Some antigenic and physical properties of virus-like particles in sera of hepatitis patients.

Authors:  L F Barker; K O Smith; W D Gehle; N R Shulman
Journal:  J Immunol       Date:  1969-06       Impact factor: 5.422

10.  Further studies on a "new" human isoprecipitin system (Australia antigen).

Authors:  H J Alter; B S Blumberg
Journal:  Blood       Date:  1966-03       Impact factor: 22.113
View more
  4 in total

1.  [Prognosis in transfusion hepatitis].

Authors:  G Jakob
Journal:  Blut       Date:  1973-01

2.  An automated passive haemagglutination technique suitable for the detection of hepatitis B virus antigen and antibody in blood donors.

Authors:  M Nelson; E J Phipps; P G Watson; J R Watts; R Zwolenski
Journal:  J Clin Pathol       Date:  1973-05       Impact factor: 3.411

Review 3.  Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues.

Authors:  Irene Rapti; Stephanos Hadziyannis
Journal:  World J Hepatol       Date:  2015-05-18

4.  Enhanced HBsAb production in pathogenesis of fulminant viral hepatitis type B.

Authors:  I L Woolf; N El Sheikh; H Cullens; W M Lee; A L Eddleston; R Williams; A J Zuckerman
Journal:  Br Med J       Date:  1976-09-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.